Richmond Pharmacology welcomes you to attend this year�s Joint Conference of Human Pharmacology Societies and 20th Anniversary of AGAH, taking place in Berlin, Germany from 31 March to April 1st.

The German AGAH e.V., the French Club Phase I, the Belgian BAPU and the British AHPPI have joined forces organising this conference, with particular focus placed on the �Exploratory Development of Modern Therapies � Biologicals, Advanced Therapies and Drug-Device Combinations�.

There will be an interesting programme offered, with an expert panel of pan-European speakers, providing ample opportunity to discuss ideas, strategies, methods, technologies and experience with the early development of modern therapies in two days of plenary sessions and workshops. The conference will provide an ideal platform for human pharmacologists working in pharmaceutical companies, CROs and academic units in Europe to come together and share knowledge and ideas.

During the conference, Dr Jorg Taubel will chair a workshop on  QT-Studies for biologicals   and Dr Ulrike Lorch will give an introduction to a forum discussion on the  Need for a uniform European accreditation system for Phase 1 units .

For a full outline of each day�s activities please click here

To register for the meeting please complete the online registration form.

We hope to see you in Berlin but if you are not able to attend, come see us at the 84th Annual Meeting of the Japanese Pharmacological Society (JPS) on 22nd to 24th, March 2011 in Yokohama Japan, where RPL will be presenting the first ever formal Japanese Caucasian bridging TQT analysis.  In addition, RPL will be appearing at the DIA Euro Meeting (booth 1541), taking place 28-31 March in Geneva, Switzerland.

March promises to be quite an eventful month for RPL and we look forward to the prospect of developing new relationships in the weeks to come. From Japan to Geneva to Berlin, here�s to crossing paths later this month!

Joint Conference of European Human Pharmacology Societies:

Latest news

Single-dose gene silencing cure for fatal heart disease comes one step closer

March 20, 2024
Richmond is delighted to be part of the first large-scale in-human trial of a genetic cure for ATTR Amyloidosis
Read more

How Does Social Time Contribute to a Positive Workplace Culture?

March 13, 2023
Read the blog by Richmond Pharmacology’s Chair of the Social Committee and Head of Marketing, Elizabeth Romano about how being social improves organisational culture and embeds the core values.
Read more

Events

ISA Symposium 2024

29-30 May 2024 
We will be attending the XIX International Symposium on Amyloidosis, taking place in Rochester, Minesota
View event